Xavier
Escoté Miró
Investigador hasta 2019
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (7)
2016
-
CDK4 is an essential insulin effector in adipocytes
Journal of Clinical Investigation, Vol. 126, Núm. 1, pp. 335-348
2015
-
HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 711.e1-711.e8
2014
-
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 6, pp. 1653-1659
2012
-
Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy
Cytokine, Vol. 58, Núm. 2, pp. 253-260
-
Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs
HIV Medicine, Vol. 13, Núm. 5, pp. 297-303
2011
-
A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy
HIV Medicine, Vol. 12, Núm. 7, pp. 428-437
-
Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: Implication of resistin
Journal of Acquired Immune Deficiency Syndromes, Vol. 57, Núm. 1, pp. 16-23